We are live on ! Find out more
ACM

Ashford Capital Management Portfolio holdings

AUM $809M
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-2.06%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.15%
5 Year Est. Return
+109.93%
10 Year Est. Return
+1,281.06%
AUM
$741M
AUM Growth
+$1.32M
Cap. Flow
+$37.7M
Cap. Flow %
5.09%
Top 10 Hldgs %
35.5%
Holding
102
New
11
Increased
27
Reduced
33
Closed
5

Top Buys

Rank Stock Value
1
FROG icon
JFrog
FROG
+$10.5M
2
AESI icon
Atlas Energy Solutions
AESI
+$10.2M
3
LGND icon
Ligand Pharmaceuticals
LGND
+$10M
4
AVPT icon
AvePoint
AVPT
+$8.6M
5
S icon
SentinelOne
S
+$7.82M

Top Sells

Rank Stock Value
1
JAMF
Jamf
JAMF
+$8.29M
2
INCY icon
Incyte
INCY
+$5.89M
3
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$4.4M
4
AXON
Axon Enterprise
AXON
+$2.95M
5
HQY icon
HealthEquity
HQY
+$2.73M

Sector Composition

Rank Sector Weight
1 Technology 20.93%
2 Healthcare 18.64%
3 Financials 16.01%
4 Industrials 10.58%
5 Communication Services 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPRT icon
1
Copart
CPRT
$25.9B
$30M 4.05%
554,262
-39,664
-7% -$2.17M
ODD icon
2
ODDITY Tech
ODD
$708M
$27.6M 3.72%
702,070
-31,410
-4% -$1.17M
TYL icon
3
Tyler Technologies
TYL
$12.2B
$27.4M 3.69%
54,408
-368
-0.7% -$170K
SKWD icon
4
Skyward Specialty Insurance
SKWD
$2.45B
$27.2M 3.67%
750,760
-4,660
-0.6% -$169K
LGND icon
5
Ligand Pharmaceuticals
LGND
$6.02B
$27.1M 3.67%
322,207
+125,672
+64% +$10M
HQY icon
6
HealthEquity
HQY
$7.91B
$26.5M 3.58%
307,682
-33,830
-10% -$2.73M
AXON
7
Axon Enterprise
AXON
$40.5B
$26M 3.51%
88,456
-9,870
-10% -$2.95M
RDVT icon
8
Red Violet
RDVT
$859M
$24.2M 3.27%
954,317
-133,623
-12% -$2.69M
CSGP icon
9
CoStar Group
CSGP
$11.3B
$23.8M 3.21%
320,788
-622
-0.2% -$52.7K
VTI icon
10
Vanguard Total Stock Market ETF
VTI
$654B
$23.1M 3.12%
86,430
-2,461
-3% -$637K
SNEX icon
11
StoneX
SNEX
$8.83B
$22.9M 3.09%
1,025,916
-63,264
-6% -$1.35M
CLBT icon
12
Cellebrite
CLBT
$3.54B
$22.8M 3.07%
1,904,280
+63,040
+3% +$704K
CVCO icon
13
Cavco Industries
CVCO
$4.39B
$20.1M 2.72%
58,100
-80
-0.1% -$29.1K
FNV icon
14
Franco-Nevada
FNV
$41.4B
$20.1M 2.71%
169,564
+51,470
+44% +$6.25M
TTD icon
15
Trade Desk
TTD
$8.13B
$20M 2.7%
205,069
-3,420
-2% -$309K
CYBR
16
DELISTED
CyberArk
CYBR
$19.6M 2.65%
71,710
+15
+0% +$3.68K
SUPN icon
17
Supernus Pharmaceuticals
SUPN
$2.68B
$19M 2.57%
711,894
-51,571
-7% -$1.49M
KNSL icon
18
Kinsale Capital Group
KNSL
$7.95B
$15.9M 2.15%
41,305
+619
+2% +$251K
INCY icon
19
Incyte
INCY
$23.5B
$14.8M 2%
244,770
-104,075
-30% -$5.89M
BRK.A icon
20
Berkshire Hathaway Class A
BRK.A
$1.07T
$13.5M 1.82%
22
– –
MKTX icon
21
MarketAxess Holdings
MKTX
$4.15B
$13.4M 1.81%
66,893
-7,384
-10% -$1.52M
NVEE
22
DELISTED
NV5 Global
NVEE
$12.9M 1.75%
556,840
+7,400
+1% +$173K
DV icon
23
DoubleVerify
DV
$1.62B
$12.6M 1.71%
648,860
+148,940
+30% +$3.6M
PGNY icon
24
Progyny
PGNY
$2.44B
$11.1M 1.5%
387,224
+75,281
+24% +$2.27M
FROG icon
25
JFrog
FROG
$9.71B
$10.8M 1.45%
+286,630
New +$10.5M
1
2 3 4 5

Similar funds

BDWCC
B&D White Capital Company Lakeway, Texas $809M AUM 19.33% 1-Year Est. Return
IPW
Impact Partnership Wealth Marietta, Georgia $810M AUM 13.94% 1-Year Est. Return
BWS
Buck Wealth Strategies Denver, Colorado $810M AUM 10.81% 1-Year Est. Return
SSG
Summit Securities Group New York $810M AUM 27.35% 1-Year Est. Return
BBI
Baxter Bros Inc Riverside, Connecticut $810M AUM 16.24% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return

Ashford Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Ashford Capital Management held 102 positions worth $741M, up 0.18% from $739M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Ashford Capital Management deployed $37.7M of net new capital in Q2 2024, opening 11 new positions and adding to 27 existing holdings. Its largest new stake was JFrog: 286,630 shares worth $10.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Incyte, an estimated $5.89M trimmed.

  • Ashford Capital Management's largest Q2 2024 buy was JFrog: 286,630 shares worth $10.8M.
  • Ashford Capital Management added most to Ligand Pharmaceuticals in Q2 2024, an estimated $10M increase.
  • Ashford Capital Management's biggest Q2 2024 reduction was Incyte, cutting an estimated $5.89M.
  • Ashford Capital Management fully exited Jamf in Q2 2024, selling an estimated $8.29M.
  • Ashford Capital Management's ten largest holdings make up 36% of its $741M portfolio in Q2 2024.
  • Ashford Capital Management opened 11 new positions and closed 5 in Q2 2024.
  • Ashford Capital Management's portfolio value rose 0.18% quarter-over-quarter to $741M.

Based on Ashford Capital Management's 13F filing for Q2 2024, filed 15 Aug 2024.